Urologic neoplasms represent the model for multidisciplinary management. With the rapid increase in our understanding of tumor biology and its extension into the clinic, there is an ever-expanding therapeutic armamentarium available to manage patients with testicular, bladder, prostate and renal cell carcinoma.
This one-day course is designed to provide a topical, clinically-based overview of many of the current therapy dilemmas faced by clinicians managing GU neoplasms, with an emphasis on the opportunities for multidisciplinary management.
Urologists, medical and radiation oncologists, and other
health care providers with an interest in the management of
patients with urologic malignancies should attend this course.